The Role of Kinins and Atrial Natriuretic Peptide on the Renal Effects of Neutral Endopeptidase Inhibitor in Normotensive and Hypertensive Rats

References

• Kauker M L. Bradykinin action on the efflux of luminal 22Na in the rat nephron. J Pharmacol Exp Ther 1980; 214: 119–123
   PubMed Web of Science ®Google Scholar
• Tomita K, Pisano J J, Knepper M A. Control of sodium and potassium transport in the cortical collecting duct of the rat. -Effects of bradykinin, vasopressin, and deoxycorticosterone. J Clin Invest 1985; 76: 132–136
   PubMed Web of Science ®Google Scholar
• Tomiyama H, Scicli A G, Scicli G M, Carretero O A. Renal effects of Fab fragments of kinin antibodies on deoxycorticosterone acetate-salt-treated rats. Hypertension 1990; 15: 413–414
   PubMedGoogle Scholar
• Shimamoto K, Ura N, Nakao T, Nishimiya T, Mita T, Kondo M, Ando T, Tanaka S, Iimura O. Role of the renal kallikrein-kinin system in sodium metabolism in normotensives and essential hypertensives. New Zealand Med J 1983; 96: 905–907
   Google Scholar
• Margolius H S, Geller R, Pisano J J, Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet 1971; ii: 1063–1065
   Google Scholar
• Carretero O A, Scicli A G. The renal kallikrein-kinin system. Am J Physiol 1980; 238: F247–F25
   PubMed Web of Science ®Google Scholar
• Ura N, Shimamoto K, Nakao T, Ogasawara A, Tanaka S, Mita T, Nishimiya T, Iimura O. The excretion of human urinary kallikrein quantity and activity in normal and low renin subgroups of essential hypertension. Clin Exp Hypertens 1983; A5: 329–337
   Google Scholar
• Iimura O, Shimamoto K, Ura N, Nakagawa M, Nishimiya T, Ando T, Yamaguchi Y, Masuda A, Ogata H, Saito S, Yamaji I, Fukuyama S. The pathophysiological role of renal dopamine, kallikrein-kinin and prostaglandin systems in essential hypertension. Agents and actions 1987; 22: 247–256
   PubMedGoogle Scholar
• Scicli A G, Rabito S, Carretero O A. Blood and urinary kinins in human subjects during normal and low sodium intake. Adv Exp Med Biol, 156A: 877–882
   Google Scholar
• Ura N, Shimamoto K, Ogata H, Sakakibara T, Ando T, Fukuyama S, Nakagawa M, Saito S, Tanaka S, Iimura O. The role of renal kininases in primary aldosteronism. Adv Exp Med Biol 1989; 247B: 145–150
   PubMedGoogle Scholar
• Mumford R A, Pierzchala P A, Strauss A W, Zimmerman M. Purification of a membrane-bound metalloendopeptidase from porcine kidney that degrades peptide hormones. Proc Natl Acad Sci 1981; 78: 6623–6627
   PubMed Web of Science ®Google Scholar
• Sakakibara T, Ura N, Shimamoto K, Ogata H, Ando T, Fukuyama S, Yamaguchi Y, Masuda A, Mori Y, Saito S, Ise T, Sasa Y, Yamauchi K, Iimura O. Localization of neutral endopeptidase in the kidney determined by stop-flow method. Adv Exp Med Biol 1989; 247B: 349–353
   PubMedGoogle Scholar
• Maeda Y, Tomita K, Ujiie K, Iino Y, Yoshiyama N, Shiigai T. Renal function, hypertension and kallikrein-kinin system, O limura, H S Margolius. University of Tokyo Press, Tokyo 1988
   Google Scholar
• Ura N, Carretero O A, Erdos E G. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kidney Int 1987; 32: 507–513
   PubMed Web of Science ®Google Scholar
• Ogata H, Ura N, Shimamoto K, Sakakibara T, Ando T, Nishimiya T, Masuda A, Ise T, Shiiki M, Uno K, Iimura O. A sensitive method for differential determination of kininase I, II and neutral endopeptidase (NEP) in human urine. Adv Exp Med Biol 1989; 247B: 343–348
   PubMedGoogle Scholar
• Ura N, Shimamoto K, Satoh S, Kuroda S, Nomura N, Ohmoto Y, Masuda A, Iimura O. Renal kininase I, kininase II and neutral endopeptidase 24.11 activities in patients with essential hypertension, primary aldosteronism and Cushing's syndrome. Hypertens Res 1993; 16: 253–258
   Google Scholar
• Blaine E H, Seymour A A, Marsh E A, Napier M A. Effects of atrial natriuretic factor on renal function and cyclic GMP production. Federation Proc 1986; 45: 2122–2127
   PubMedGoogle Scholar
• Sonnenberg H, Honrath U, Chong C K, Wilson D R. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J physiol 1986; 250: F963–F96
   PubMed Web of Science ®Google Scholar
• Stephenson S L, Kenny A J. The hydrolysis of alpha human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase 24.11. Biochem J 1987; 243: 183–187
   PubMed Web of Science ®Google Scholar
• Maack T, Suzuki M, Almeida F A, Nussensweig D, Scarborough R M, McEnroe G A. Physiological role of silent receptors of atrial natriuretic factor. Science 1987; 238: 675–678
   PubMed Web of Science ®Google Scholar
• Gros C, Souque A, Schwartz J C, Duchier J, Cournot A, Baumer P, Lecomte J M. Protection of atrial natriuretic factor against degradation: Diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan. Proc Natl Acad Sci 1989; 86: 7580–7584
   PubMed Web of Science ®Google Scholar
• Seymour A, Fennell S A, Swerdel J N. Potentiation of renal effects of atrial natriuretic factor-(99–126) by SQ 29072. Hypertension 1989; 14: 87–97
   PubMed Web of Science ®Google Scholar
• Sybertz E J, Chiu P JS, Vemulapalli S, Pitts B, Foster C J, Watkins R W, Barnett A. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats. J Pharmacol Exp Ther 1989; 250: 624–631
   PubMed Web of Science ®Google Scholar
• Richards A M, Wittert G, Espiner E A, Yandel T G, Frampton C, Ikram H. Prolonged inhibition of endopeptidase 24.11 in normal man: renal, endocrine and haemodynamic effects. J Hypertens 1991; 9: 955–962
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Ando T, Nakao T, Sakuma M, Miyahara M. A sensitive radioimmunoassay method for urinary kinins in man. J Lab Clin Med 1978; 91: 721–728
   PubMed Web of Science ®Google Scholar
• Hirata Y, Matsuoka H, Hayakawa H, Sugimoto T, Suzuki E, Sugimoto T, Kangawa K, Matsuo H. Role of endogeneous atrial natriuretic peptide in regulating sodium excretion in spontaneously hypertensive rats. Hypertension 1991; 17: 1025–1032
   PubMed Web of Science ®Google Scholar
• Shepperson N B, Barclay P L, Bennet J A, Samuels G MR. Inhibition of neutral endopeptidase (EC 3.4.24.11) leads to an atrial natriuretic factor-mediated natriuretic, diuretic and antihypertensive response in rodents. Clin Sci 1991; 80: 265–269
   PubMed Web of Science ®Google Scholar
• Smits G J, McGraw D E, Trapani A J. Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects. Am J Physiol 1990; 258: F1417–F142
   PubMed Web of Science ®Google Scholar
• Chiu P JS, Tetzloff G, Romano M T, Foster C J, Sybertz E J. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. Am J Physiol 1991; 260: R208–R21
   PubMed Web of Science ®Google Scholar
• Chevalier R L, Garmey M, Scarborough R M, Linden J, Gomez R A, Peach M J, Carey R M. Inhibition of ANP clearance receptors and endopeptidase 24.11 in maturing rats. Am J Physiol 1991; 260: R1218–R122
   PubMed Web of Science ®Google Scholar
• Singer D RJ, Markandu N D, Buckley M G, Miller M A, Sagnella G A, MacGregor G A. Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension. Hypertension 1991; 18: 798–804
   PubMed Web of Science ®Google Scholar
• Richards A M, Crozier I G, Kosoglou T, Rallings M, Espiner E A, Nicholls M G, Yandel T G, Ikram H, Frampton C. Endopeptidase 24.11 inhibition by SCH 42495 in essential hypertension. Hypertension 1993; 22: 119–126
   PubMed Web of Science ®Google Scholar
• Lefrancois P, Clerc G, Duchier J, Lim C, Lecomyte J M, Gros C, Schwartz J C. Antihypertensive activity of sinorphan. Lancet 1990; 336: 307–308
   PubMed Web of Science ®Google Scholar
• Ogihara T, Rakugi H, Masuo K, Yu H, Nagano M, Mikami H. Antihypertensive effects of the neutral endopeptidase inhibitor SCH 42495 in essential hypertension. Am J Hypertens 1994; 7: 943–947
   PubMed Web of Science ®Google Scholar